reteplase + NE01

**Reteplase + NE01** is a combination of reteplase, a recombinant thrombolytic agent consisting of the kringle 2 and protease domains of human tissue-type plasminogen activator (tPA), with NE01, a novel thrombolytic enhancer or adjunct component aimed at improving efficacy or safety. Reteplase functions by cleaving the Arg/Val bond in plasminogen to generate plasmin, which degrades the fibrin matrix of thrombi, primarily used for acute myocardial infarction (AMI) to restore coronary artery patency. The addition of NE01 likely optimizes thrombolysis, potentially reducing dosing requirements, bleeding risks, or enhancing clot dissolution speed, though specific clinical data on this pairing remains limited.